Product NDC: | 0135-0482 |
Proprietary Name: | Tums |
Non Proprietary Name: | famotidine, calcium carbonate and magnesium hydroxide |
Active Ingredient(s): | 800; 10; 165 mg/1; mg/1; mg/1 & nbsp; famotidine, calcium carbonate and magnesium hydroxide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0135-0482 |
Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA077355 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110608 |
Package NDC: | 0135-0482-02 |
Package Description: | 50 TABLET, CHEWABLE in 1 BOTTLE (0135-0482-02) |
NDC Code | 0135-0482-02 |
Proprietary Name | Tums |
Package Description | 50 TABLET, CHEWABLE in 1 BOTTLE (0135-0482-02) |
Product NDC | 0135-0482 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | famotidine, calcium carbonate and magnesium hydroxide |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20110608 |
Marketing Category Name | ANDA |
Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
Substance Name | CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE |
Strength Number | 800; 10; 165 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |